Palomino Laboratories (PALX) Change in Accured Expenses (2023 - 2025)

Palomino Laboratories has disclosed Change in Accured Expenses across 3 years of filings, most recently posting $464910.0 for Q3 2025.

• In Q3 2025, Change in Accured Expenses rose 16486.16% year-over-year to $464910.0; the TTM figure through Sep 2025 stood at $458934.0 (up 2413.74% YoY), while the FY2024 annual figure was $5443.0, up 143.75% from the prior year.
• Change in Accured Expenses came in at $464910.0 for Q3 2025 at Palomino Laboratories, up from -$5035.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $464910.0 in Q3 2025 to a low of -$41256.0 in Q4 2024.
• Average Change in Accured Expenses over 3 years is $59648.9, with a median of -$177.5 recorded in 2024.
• The largest YoY upside for Change in Accured Expenses was 16486.16% in 2025 against a maximum downside of 59.44% in 2025.
• Over 3 years, Change in Accured Expenses stood at -$28442.0 in 2023, then plunged by 45.05% to -$41256.0 in 2024, then surged by 1226.89% to $464910.0 in 2025.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $464910.0 in Q3 2025, -$5035.0 in Q2 2025, and $40315.0 in Q1 2025.